top of page

The MINT Trial

The MINT Trial

NEJM

November 11, 2023

Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia

Mazen Kherallah

Summarized by: 

PICO Framework:

  • Population: Patients with myocardial infarction and a hemoglobin level of less than 10 g per deciliter.

  • Intervention: Liberal transfusion strategy (hemoglobin cutoff for transfusion <10 g per deciliter).

  • Comparison: Restrictive transfusion strategy (hemoglobin cutoff for transfusion 7 or 8 g per deciliter).

  • Outcome: Primary outcome was a composite of myocardial infarction or death at 30 days.


Methods:

  • Design: Phase 3, interventional, randomized controlled trial.

  • Participants: 3504 patients with myocardial infarction and hemoglobin levels <10 g/dL.


Results:

  • Transfusion: Average number of red-cell units transfused was 0.7±1.6 in the restrictive group and 2.5±2.3 in the liberal group.

  • Hemoglobin Levels: The mean hemoglobin level was 1.3 to 1.6 g/dL lower in the restrictive group than in the liberal group on days 1 to 3 after randomization.

  • Primary Outcome: Occurred in 16.9% of patients in the restrictive group and 14.5% in the liberal group (risk ratio 1.15; 95% CI, 0.99 to 1.34; P=0.07).

  • Mortality: 9.9% in the restrictive group and 8.3% in the liberal group (risk ratio, 1.19; 95% CI, 0.96 to 1.47).

  • Myocardial Infarction: Occurred in 8.5% of the restrictive group and 7.2% of the liberal group (risk ratio, 1.19; 95% CI, 0.94 to 1.49).


Conclusions:

  • The liberal transfusion strategy did not significantly reduce the risk of recurrent myocardial infarction or death at 30 days compared to the restrictive strategy.

  • However, the potential harms associated with the restrictive transfusion strategy cannot be excluded.


Implications for Intensivists:

  • This study suggests that a liberal transfusion strategy in acute myocardial infarction patients with anemia does not confer a significant advantage in reducing the risk of myocardial infarction or death within 30 days.

  • The marginally higher rates of adverse outcomes in the restrictive group, although not statistically significant, warrant careful consideration in clinical decision-making.

  • Intensivists should weigh the risks and benefits of transfusion thresholds on an individual patient basis, taking into account other clinical factors.

  • More inclined to keep Hg level above 8 in acute mycardial infarction and acute coronary syndrome.

0

bottom of page